I

IX Biopharma Ltd
SGX:42C

Watchlist Manager
IX Biopharma Ltd
SGX:42C
Watchlist
Price: 0.02 SGD 11.11% Market Closed
Market Cap: 17.8m SGD

Intrinsic Value

42C's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one 42C stock under the Base Case scenario is 0.03 SGD. Compared to the current market price of 0.02 SGD, IX Biopharma Ltd is Undervalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

42C Intrinsic Value
0.03 SGD
Undervaluation 31%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation History
IX Biopharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
42C
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for 42C cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

IX Biopharma Ltd
SGX:42C
SG
Pharmaceuticals
Market Cap
17.7m SGD
IPO
Jul 22, 2015
SG
Pharmaceuticals
Market Cap
17.7m SGD
IPO
Jul 22, 2015
Price
S$false
EPS
S$false
Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 42C?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about IX Biopharma Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
IX Biopharma Ltd

Current Assets 5.6m
Cash & Short-Term Investments 2.1m
Receivables 2.1m
Other Current Assets 1.4m
Non-Current Assets 7.5m
PP&E 7.1m
Intangibles 273k
Other Non-Current Assets 92k
Efficiency

Free Cash Flow Analysis
IX Biopharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
IX Biopharma Ltd

Revenue
7m SGD
Cost of Revenue
-5.7m SGD
Gross Profit
1.3m SGD
Operating Expenses
-8.4m SGD
Operating Income
-7.1m SGD
Other Expenses
-2.6m SGD
Net Income
-9.7m SGD
Fundamental Scores

42C Profitability Score
Profitability Due Diligence

IX Biopharma Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

IX Biopharma Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

42C Solvency Score
Solvency Due Diligence

IX Biopharma Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Long-Term Solvency
Short-Term Solvency
32/100
Solvency
Score

IX Biopharma Ltd's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

42C Price Targets Summary
IX Biopharma Ltd

There are no price targets for 42C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

IX Biopharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for 42C is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one 42C stock?

The intrinsic value of one 42C stock under the Base Case scenario is 0.03 SGD.

Is 42C stock undervalued or overvalued?

Compared to the current market price of 0.02 SGD, IX Biopharma Ltd is Undervalued by 31%.

Back to Top